Specialty Generics can help address escalating healthcare costs for both individual consumers and the healthcare system.
Values
-
Our company is our people. We continue to invest in the training and development of our highly qualified and experienced team to bring the best expertise to our operations.
-
We use advanced manufacturing technologies to provide specialty treatments to patients, many of which offer fewer side effects and greater convenience, promoting improved patient compliance to treatment regimens.
We aim to provide expanded access to affordable specialty medications to help address the escalation in cost for both the healthcare system and individual consumers.
About Alvogen
Alvogen is focused to:
- Expand our leading R&D pipeline
- Harness our world-class manufacturing capabilities
- Invest and expand production capabilities to further support manufacturing of high-tech products
- Leverage the extensive portfolio, pipeline and resources of our affiliates
- Broaden development capabilities through partnerships, alliances, mergers and acquisitions
- Provide patients with access to affordable specialty medications
For more information about Alvogen, please visit our Newsroom.
Alvogen's drug development efforts provide expanded access to affordable specialty medications to help address the challenges faced by our society resulting from ever escalating healthcare costs for both the healthcare system and individual consumers.
Doug Drysdale, CEO
Doug Drysdale has been the driving force behind over 100 pharmaceutical and biotech transactions. For almost 20 years, he has been applying his leadership skills and strategic vision to building and growing complex, multi-region businesses.